Inventor · Stony Brook, NY, US

Wayne Koff

25Patents
5h-index
29Co-inventors
69Inventor score

Filing activity: Oct 26, 2000 → Jun 5, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US9464131B2 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Chemistry; Metallurgy 14 Active
US9051362B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 14 Active
US10087239B2 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Chemistry; Metallurgy 12 Active
US6531313B1 Invasive bacterial vectors for expressing alphavirus replicons Emerging Cross-Sectional Technologies 12 Expired
US8586056B2 HIV-1 envelope glycoprotein Chemistry; Metallurgy 11 Active
US10093720B2 Broadly neutralizing antibody and uses thereof Chemistry; Metallurgy 4 Active
US11319362B2 Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Chemistry; Metallurgy 2 Active
USRE49037E1 Broadly neutralizing antibody and uses thereof General 1 Active
US12312396B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US10894080B2 Transgenic VERO-CD4/CCR5 cell line Chemistry; Metallurgy 0 Active
US9796774B2 HIV-1 broadly neutralizing antibodies Chemistry; Metallurgy 0 Active
US9925258B2 Replication-competent VSV-HIV Env vaccines Chemistry; Metallurgy 0 Active
US12018067B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US10239934B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US11845789B2 Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Chemistry; Metallurgy 0 Active
US8105600B2 Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 Env Chemistry; Metallurgy 0 Active
US10279027B2 Transgenic Vero-CD4/CCR5 cell line Chemistry; Metallurgy 0 Active
US10836811B2 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Chemistry; Metallurgy 0 Active
USRE50268E1 Broadly neutralizing antibody and uses thereof General 0 Active
US10865234B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US11584789B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US9382311B2 HIV-1 broadly neutralizing antibodies Chemistry; Metallurgy 0 Active
US9920111B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US10407493B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US12410243B2 Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.